Benzinga | Sep 8, 2021 04:33PM EDT

Streamline Health Solns Q2 Sales $2.90M Miss $3.15M Estimate

Streamline Health Solns (NASDAQ:STRM) reported quarterly sales of $2.90 million which missed the analyst consensus estimate of $3.15 million by 7.94 percent. This is a 0.45 percent increase over sales of $2.89 million the same period last year.